Souhir Abid
Sakakah, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pharmacophore-guided computational profiling of thiadiazole-based therapeutic addressing flap necrosis: Molecular simulation, DFT mapping, pharmacokinetic and kinetic evaluation.
Journal: Computational biology and chemistry
Published: June 25, 2026
Synthesis and structural characterization of coumarin-hydrazone derivatives as antiplatelet agents: in vitro and in silico evaluation of activity and toxicity.
Journal: 3 Biotech
Published: May 10, 2025
Novel Coumarin-Hydrazone Hybrids as Potential Antiplatelet Agents: Microwave-Assisted Synthesis, Characterization, In Vitro and In Silico Biological Evaluations and Toxicity Assessment.
Journal: Chemistry & biodiversity
Published: January 09, 2025
Design and Synthesis of Novel N-Benzylidene Derivatives of 3-Amino-4-imino-3,5-dihydro-4H-chromeno[2,3-d]pyrimidine under Microwave, In Silico ADME Predictions, In Vitro Antitumoral Activities and In Vivo Toxicity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 18, 2024
Highly Flexible Poly(1,12-dodecylene 5,5'-isopropylidene-bis(ethyl 2-furoate)): A Promising Biobased Polyester Derived from a Renewable Cost-Effective Bisfuranic Precursor and a Long-Chain Aliphatic Spacer.
Journal: Molecules (Basel, Switzerland)
Published: March 31, 2023
A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes and electrocardiogram.
Journal: Clinical and experimental pharmacology & physiology
Published: July 29, 2021
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis.
Journal: ACS infectious diseases
Published: February 22, 2021
Potential effect of new (E)-4-hydroxy -N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against acute myocardial infarction: Haemodynamic, biochemical and histological studies.
Journal: Clinical and experimental pharmacology & physiology
Published: July 17, 2020
Cardiopreventive capacity of a novel (E)-N'-(1-(7-methoxy-2-oxo-2H-chromen-3-yl) ethylidene)-4-methylbenzenesulfonohydrazide against isoproterenol-induced myocardial infarction by moderating biochemical, oxidative stress, and histological parameters.
Journal: Journal of biochemical and molecular toxicology
Published: January 19, 2020
Preparation, characterization and degradation study of novel sulfonated furanic poly(ester-amide)s.
Journal: Designed monomers and polymers
Published: November 24, 2019
(E)-N'-(1-(7-Hydroxy-2-Oxo-2H-Chromen-3-Yl) Ethylidene) Benzohydrazide, a Novel Synthesized Coumarin, Ameliorates Isoproterenol-Induced Myocardial Infarction in Rats through Attenuating Oxidative Stress, Inflammation, and Apoptosis.
Journal: Oxidative medicine and cellular longevity
Published: November 02, 2019
(E)-N'-(1-(3-oxo-3H-benzo[f]chromen-2-yl)ethylidene)benzohydrazide protecting rat heart tissues from isoproterenol toxicity: Evidence from in vitro and in vivo tests.
Journal: European journal of pharmacology
Published: October 18, 2019
Last Updated: 09/26/2026